Stability of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine samples stored atvarious temperatures

Journal of Analytical Toxicology

Volumn 34, Issue 7, 2010, Pages 411-415

  Xia, Yang ^a   Bernert, John T ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; GLUCURONIDE; NITROSAMINE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTAN 1 OL; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTAN-1-OL; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; BIOLOGICAL MARKER; PYRIDINE DERIVATIVE;

ARTICLE; CALIBRATION; CHROMATOGRAPHY; DRUG STABILITY; ELUTION; ENZYME INACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; LIQUID LIQUID EXTRACTION; STORAGE TEMPERATURE; TANDEM MASS SPECTROMETRY; URINALYSIS; HUMAN; LABORATORY DIAGNOSIS; METABOLISM; TEMPERATURE; TIME; TOBACCO; URINE;

NICOTIANA TABACUM;

BIOLOGICAL MARKERS; GLUCURONIDES; HUMANS; NITROSAMINES; PYRIDINES; SPECIMEN HANDLING; TEMPERATURE; TIME FACTORS; TOBACCO;

EID: 78650106890     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/34.7.411     Document Type: Article

References (12)

1. U.S. DHHS, Public Health Serv. 2004. The Health Consequences of Smoking: A Report of the Surgeon General. GPO,Washington, D.C.
2. American Cancer Society. Cancer Facts & Figures 2003. American Cancer Society, 2003. http://www.cancer.org/downloads/STT/CAFF2003PWSecured.pdf.
3. A.J. Sasco, M.B. Secretan, and K. Straif. Tobacco smoking and cancer: a brief review of recent epidemiological evidence. Lung Cancer 45 Suppl. 2: 53-59 (2004).
4. D. Hoffmann and I. Hoffmann. The changing cigarette, 1950-1995. J. Toxicol. Environ. Health 50: 307-364 (1997).
5. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 83, Tobacco Smoke and Involuntary Smoking (2004)
6. R.A. Andersen and T.R. Kemp. Accumulation of 4-(N-methyl-Nnitrosamino)-1-(3-pyridyl)-1-butanone in alkaloid genotypes of burley tobacco during postharvest processing: comparisons with N'-nitrosonornicotine and probable nitrosamine precursors. Cancer Res. 45: 5287-5293 (1985).
7. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 89, Smokeless Tobacco and Some Tobacco-specific NNitrosamines, 2007.
8. J.P. Richie, Jr., S.G. Carmella, J.E. Muscat, D.G. Scott, S.A. Akerkar, and S.S. Hecht. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers. Cancer Epidemiol. Biomark. Prev. 6: 783-790 (1997).
9. T. Zhang, B. Lai, L. Duan and X.Wang. Detection of metabolites of tobacco-specific nitrosamine 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone in lung cancer smokers' urine. Chin. J. Lung Cancer 9: 231-235 (2006)
10. S.G. Carmella, S.A. Akerkar, J.P. Richie, and S.S. Hecht. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine. Cancer Epidemiol. Biomarkers Prev. 4: 635-642 (1995).
11. Y. Xia, J. McGuffey, S. Bhattacharyya, B. Sellergren, E. Yilmaz, L. Wang, and J.T. Bernert. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Anal. Chem. 77: 7639-7645 (2005).
12. M.S. Tydeman and T.B.L. Kirkwood. Design and analysis of accelerated degradation tests for the stability of biological standards I. Properties of maximum likelihood estimators. J. Biol. Stand. 12: 195-206 (1984).